Molecules (Sep 2020)

Synthetic Analogues of Aminoadamantane as Influenza Viral Inhibitors—In Vitro, In Silico and QSAR Studies

  • Radoslav Chayrov,
  • Nikolaos A. Parisis,
  • Maria V. Chatziathanasiadou,
  • Eleni Vrontaki,
  • Kalliopi Moschovou,
  • Georgia Melagraki,
  • Hristina Sbirkova-Dimitrova,
  • Boris Shivachev,
  • Michaela Schmidtke,
  • Yavor Mitrev,
  • Martin Sticha,
  • Thomas Mavromoustakos,
  • Andreas G. Tzakos,
  • Ivanka Stankova

DOI
https://doi.org/10.3390/molecules25173989
Journal volume & issue
Vol. 25, no. 17
p. 3989

Abstract

Read online

A series of nineteen amino acid analogues of amantadine (Amt) and rimantadine (Rim) were synthesized and their antiviral activity was evaluated against influenza virus A (H3N2). Among these analogues, the conjugation of rimantadine with glycine illustrated high antiviral activity combined with low cytotoxicity. Moreover, this compound presented a profoundly high stability after in vitro incubation in human plasma for 24 h. Its thermal stability was established using differential and gravimetric thermal analysis. The crystal structure of glycyl-rimantadine revealed that it crystallizes in the orthorhombic Pbca space group. The structure–activity relationship for this class of compounds was established, with CoMFA (Comparative Molecular Field Analysis) 3D-Quantitative Structure Activity Relationships (3D-QSAR) studies predicting the activities of synthetic molecules. In addition, molecular docking studies were conducted, revealing the structural requirements for the activity of the synthetic molecules.

Keywords